Peripheral arterial disease (PAD) is a common circulatory problem. In 2010 almost 18 million U.S. citizens suffered from PAD. Reflecting the aging population this number is projected to increase to 21 million by 2020. Critical limb ischemia (CLI), the most severe and deadly form of the disease, currently afflicts 2.8 to 3.5 million of those with PAD. By 2020, the U.S.prevalence of CLI is forecast to grow to between 3.6 and 4.5 million. Among PAD patients,about 1-3% will develop CLI [1].
A Phase II Trial of Autologous Transplantation of Bone Marrow Stem Cells For Critical Limb Ischemia: Results of N.A.P.L.E.S. Study Schiavetta Alessandro
SIGNORIELLO, Giuseppe;Cobellis G.
2012
Abstract
Peripheral arterial disease (PAD) is a common circulatory problem. In 2010 almost 18 million U.S. citizens suffered from PAD. Reflecting the aging population this number is projected to increase to 21 million by 2020. Critical limb ischemia (CLI), the most severe and deadly form of the disease, currently afflicts 2.8 to 3.5 million of those with PAD. By 2020, the U.S.prevalence of CLI is forecast to grow to between 3.6 and 4.5 million. Among PAD patients,about 1-3% will develop CLI [1].File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
